Jason Wittes

Stock Analyst at Roth Capital

(3.28)
# 1,075
Out of 5,042 analysts
61
Total ratings
49.06%
Success rate
3.86%
Average return

Stocks Rated by Jason Wittes

ARS Pharmaceuticals
Sep 4, 2025
Initiates: Buy
Price Target: $40
Current: $9.11
Upside: +339.08%
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405$456
Current: $381.79
Upside: +19.44%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $1.95
Upside: +720.51%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15$16
Current: $2.51
Upside: +537.45%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $15.97
Upside: +37.76%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60$72
Current: $78.52
Upside: -8.30%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $5.12
Upside: +114.84%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100$115
Current: $62.29
Upside: +84.62%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $12.38
Upside: +190.79%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.46
Upside: +47.45%
Initiates: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
Reinstates: Buy
Price Target: $100
Current: $89.21
Upside: +12.10%
Reiterates: Buy
Price Target: $5
Current: $3.09
Upside: +61.81%
Initiates: Buy
Price Target: $9
Current: $1.57
Upside: +473.25%
Initiates: Buy
Price Target: $75
Current: $32.87
Upside: +128.17%
Initiates: Buy
Price Target: $22
Current: $16.11
Upside: +36.56%
Initiates: Neutral
Price Target: $120
Current: $103.03
Upside: +16.47%
Initiates: Buy
Price Target: $206
Current: $147.78
Upside: +39.40%
Reinstates: Buy
Price Target: $145
Current: $184.82
Upside: -21.55%
Initiates: Buy
Price Target: $15
Current: $16.83
Upside: -10.85%
Initiates: Buy
Price Target: $200
Current: $13.75
Upside: +1,354.55%
Initiates: Buy
Price Target: $26
Current: $33.34
Upside: -22.00%